Joint Approach

In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Gina Suh, MD, Ken Urish, MD, PhD, and Ray Schuch, PhD on the topic of innovation in treatment of PJI's with phage lysins. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, genex®, and SYNICEMTM, please click here 
FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Gina Suh, MD, Ken Urish, MD, PhD, and Ray Schuch, PhD in part 1 of this 2-part conversation on the topic of innovation in treatment of PJI's with phage lysins. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, genex®, and SYNICEMTM, please click here

In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with P. Maxwell Courtney, MD, Katherine Belden, MD, Poorani Sekar, MD on the topic of long term antibiotic usage at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to Peptilogics for sponsoring this episode. For more information about their clinical trials, email clinicaltrials@peptilogics.com, or visit Peptilogics.com.
FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with P. Maxwell Courtney, MD, Katherine Belden, MD, and Poorani Sekar, MD in part 1 of this 2-part conversation on the topic of long term antibiotic usage at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to Peptilogics for sponsoring this episode. For more information about their clinical trials, email clinicaltrials@peptilogics.com, or visit Peptilogics.com.
FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with  Michael Henry, MD and Daisuke Furukawa, MD on the topic of Suppressive Antibiotic Therapy (SAT) at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com.